Top Markets
Coin of the day
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Rangering i aksjer #25246
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Aksjekurs
$23.57
Sist synkronisert: 2026-08-20
Markedsverdi
$51.76M
Endring (1 dag)
-0.08%
Endring (1 år)
289.59%
Land
US
Handel Apollomics, Inc. (APLM)

Kategori

Historikk for aksjesplitt for Apollomics, Inc. (APLM)
Aksjen Apollomics, Inc. (symbol: APLM) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 21, 2026.
Én APLM-aksje kjøpt før Aug 21, 2026 tilsvarer i dag 0 APLM-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US